After its 25%+ fall, what am I doing about Clinigen shares?
More on: Image: Dechra Pharmaceuticals
Clinigen(LSE: CLIN) is a pharmaceutical and services company that provides access to medicines on a global scale. While this business model has proved effective over the last few years, with consistent strong financial results being the evidence of this, the pandemic has adversely affected the company. Today, this resulted in the pharmaceutical company issuing a profit-warning, causing the Clinigen share price to fall 25+%. It’s down by 24% over 12 months. Does this present the perfect opportunity to buy or is there further to fall?
Profit warning
5 Min Read
NEW YORK/LONDON (Reuters) - World stock markets closed near record highs and U.S. bond yields fell on Wednesday as some of U.S. President Joe Biden’s stimulus efforts appeared to be on the rocks, boosting the appeal of technology stocks as inflation pressures ease.
FILE PHOTO: The front facade of the New York Stock Exchange (NYSE) is seen in New York City, U.S., May 4, 2021. REUTERS/Brendan McDermid
A little-noticed ruling by Senate parliamentarian Elizabeth MacDonough in May said Democrats can only use “reconciliation” once in a fiscal year to circumvent legislation that requires 60 votes. Democrats passed Biden’s $1.9 trillion COVID-19 relief package in March through reconciliation.
World stocks hovered near record highs and U.S. bond yields fell on Wednesday as some of U.S. President Joe Biden's stimulus efforts appeared to be on the rocks, boosting the appeal of technology stocks as future inflation pressures ease.
Sun 6 Jun 2021 19.01 EDT
Foreign investors now own 66% of UK-listed shares, up from 64% in 2019, according to analysis of the London market that shows a steep decline in domestic holdings by British shareholders.
Europeans have increased their holdings in companies quoted on the London Stock Exchange the most in the last two years, ahead of US investors and increasing interest from Chinese-based funds, said the investor relations consultancy firm Orient Capital.
British pension funds own only 2% of the London stock market following a steep decline in recent years.
In 2013 British pension funds owned 8% of London-listed shares by value, but over eight years that has dropped by three-quarters.